This article is more than 5 years old. Information may no longer be current.
Loss of Response in the Treatment of Crohn’s Disease: A Case Study
Click Here to Manage Email Alerts
Anti-TNF agents are effective for inducing and maintaining remission in patients with Crohn’s disease. However, a significant number of patients who initially respond to treatment eventually lose response and experience a flare of their symptoms. Dr. Gary Lichtenstein explores this issue through the presentation of a case of a young man with Crohn’s disease and secondary nonresponse to biologic therapy.
Learning Objectives
Upon successful completion of this educational activity, participants should be better able to summarize the benefits and limitations of available therapeutic agents for the management of IBD.
To see this Education Lab activity, click here.
Overview
Author(s)/Faculty: Gary R. Lichtenstein, MD
Source: Healio Gastroenterology Education Lab
Type: Mutlimedia
Articles/Items: 4
Release Date: 9/23/2016
Expiration Date: 9/22/2017
Credit Type: CME
Number of Credits: 0.25
Cost: Free
Provider: Vindico Medical Education
CME Information
Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.
Support Statement: This activity is supported by an educational grant from Receptos Inc.
Target Audience: The intended audience for this activity is gastroenterologists and other health care professionals involved in the treatment of patients with inflammatory bowel disease (IBD).